Skip to main content
SpringerLink
Log in

Using Lithium in Children and Adolescents with Bipolar Disorder: Efficacy, Tolerability, and Practical Considerations

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Lithium has been an intriguing treatment option in psychiatry for over a century. While seemingly just a simple elemental compound, it has powerful treatment effects for both depression and bipolar disorder. The evidence base for treatment of pediatric bipolar disorder is relatively small, but, in recent years, additional clinical trial data have enabled lithium to re-emerge as a valuable and, in many cases, preferred treatment. Pharmacologically, lithium is complex, with varied effects at both intracellular and extracellular levels. As a treatment for bipolar disorder in pediatrics, lithium is challenging, given its narrow therapeutic window and myriad of potential side effects. However, the efficacy of lithium continues to match that of newer pharmacologic agents, and its tolerability has been shown to be comparable with more commonly prescribed medications. Lithium is still one of few drugs that have been proven to reduce the risk of suicidality, and it may have utility in illnesses beyond affective disorders. Practically, as a primary agent or as an adjunct, lithium continues to claim a rightful place in the treatment armamentarium of child psychiatry. New dosing paradigms have improved tolerability and reduced potential side effects. Recent evidence affirms that lithium is effective for pediatric bipolar disorder in multiple phases of the illness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Shorter E. The history of lithium therapy. Bipolar Disord. 2009;11(Suppl 2):4–9. https://doi.org/10.1111/j.1399-5618.2009.00706.x.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17(4):250–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Carlson GA, Glovinsky I. The concept of bipolar disorder in children: a history of the bipolar controversy. Child Adolesc Psychiatr Clin N Am. 2009;18(2):257–71, vii. https://doi.org/10.1016/j.chc.2008.11.003.

  4. Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010;71(7):864–72. https://doi.org/10.4088/JCP.08m04994yel.

    Article  PubMed  Google Scholar 

  5. McClellan J, Kowatch R, Findling RL, Work Group on Quality I. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):107–25. https://doi.org/10.1097/01.chi.0000242240.69678.c4.

    Article  PubMed  Google Scholar 

  6. Van Meter AR, Moreira AL, Youngstrom EA. Meta-analysis of epidemiologic studies of pediatric bipolar disorder. J Clin Psychiatry. 2011;72(9):1250–6. https://doi.org/10.4088/JCP.10m06290.

    Article  PubMed  Google Scholar 

  7. Kessler RC, Avenevoli S, Green J, Gruber MJ, Guyer M, He Y, et al. National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments. J Am Acad Child Adolesc Psychiatry. 2009;48(4):386–99. https://doi.org/10.1097/CHI.0b013e31819a1cbc.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry. 1995;34(4):454–63.

    Article  PubMed  CAS  Google Scholar 

  9. Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS. Defining clinical phenotypes of juvenile mania. Am J Psychiatry. 2003;160(3):430–7.

    Article  PubMed  Google Scholar 

  10. Hauser M, Galling B, Correll CU. Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic review of prevalence and incidence rates, correlates, and targeted interventions. Bipolar Disord. 2013;15(5):507–23. https://doi.org/10.1111/bdi.12094.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Berry EA, Heaton PT, Kelton CM. National estimates of the inpatient burden of pediatric bipolar disorder in the United States. J Ment Health Policy Econ. 2011;14(3):115–23.

    PubMed  Google Scholar 

  12. Sani G, Perugi G, Tondo L. Treatment of bipolar disorder in a lifetime perspective: is lithium still the best choice? Clin Drug Investig. 2017;37(8):713–27. https://doi.org/10.1007/s40261-017-0531-2.

    Article  PubMed  Google Scholar 

  13. Findling RL, Landersdorfer CB, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, et al. First-dose pharmacokinetics of lithium carbonate in children and adolescents. J Clin Psychopharmacol. 2010;30(4):404–10. https://doi.org/10.1097/JCP.0b013e3181e66a62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Landersdorfer CB, Findling RL, Frazier JA, Kafantaris V, Kirkpatrick CM. Lithium in paediatric patients with bipolar disorder: implications for selection of dosage regimens via population pharmacokinetics/pharmacodynamics. Clin Pharmacokinet. 2017;56(1):77–90. https://doi.org/10.1007/s40262-016-0430-3.

    Article  PubMed  CAS  Google Scholar 

  15. Findling RL, Robb A, McNamara NK, Pavuluri MN, Kafantaris V, Scheffer R, et al. Lithium in the acute treatment of bipolar I disorder: a double-blind, placebo-controlled study. Pediatrics. 2015;136(5):885–94. https://doi.org/10.1542/peds.2015-0743.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Findling RL, Kafantaris V, Pavuluri M, McNamara NK, Frazier JA, Sikich L, et al. Post-acute effectiveness of lithium in pediatric bipolar I disorder. J Child Adolesc Psychopharmacol. 2013;23(2):80–90. https://doi.org/10.1089/cap.2012.0063.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Findling RL, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, Frazier JA, et al. Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol. 2011;21(3):195–205. https://doi.org/10.1089/cap.2010.0084.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Findling RL, Frazier JA, Kafantaris V, Kowatch R, McClellan J, Pavuluri M, et al. The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation. Child Adolesc Psychiatry Ment Health. 2008;2(1):21.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Alda M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry. 2015;20(6):661–70. https://doi.org/10.1038/mp.2015.4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Diniz BS, Machado-Vieira R, Forlenza OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat. 2013;9:493–500. https://doi.org/10.2147/NDT.S33086.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Mauer S, Vergne D, Ghaemi SN. Standard and trace-dose lithium: a systematic review of dementia prevention and other behavioral benefits. Aust N Z J Psychiatry. 2014;48(9):809–18. https://doi.org/10.1177/0004867414536932.

    Article  PubMed  Google Scholar 

  22. Arancibia A, Corvalan F, Mella F, Concha L. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations. Int J Clin Pharmacol Ther Toxicol. 1986;24(5):240–5.

    PubMed  CAS  Google Scholar 

  23. Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. J Clin Pharmacol. 1994;34(4):280–5.

    Article  PubMed  CAS  Google Scholar 

  24. Malhi GS, Gessler D, Outhred T. The use of lithium for the treatment of bipolar disorder: recommendations from clinical practice guidelines. J Affect Disord. 2017;217:266–80. https://doi.org/10.1016/j.jad.2017.03.052.

    Article  PubMed  CAS  Google Scholar 

  25. Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M. Role of lithium augmentation in the management of major depressive disorder. CNS Drugs. 2014;28(4):331–42. https://doi.org/10.1007/s40263-014-0152-8.

    Article  PubMed  CAS  Google Scholar 

  26. Selle V, Schalkwijk S, Vazquez GH, Baldessarini RJ. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Pharmacopsychiatry. 2014;47(2):43–52. https://doi.org/10.1055/s-0033-1363258.

    Article  PubMed  CAS  Google Scholar 

  27. Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2014;2:15. https://doi.org/10.1186/s40345-014-0015-8.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Nelson JC, Baumann P, Delucchi K, Joffe R, Katona C. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression. J Affect Disord. 2014;168:269–75. https://doi.org/10.1016/j.jad.2014.05.053.

    Article  PubMed  CAS  Google Scholar 

  29. Wingard L, Boden R, Brandt L, Tiihonen J, Tanskanen A, Kieler H, et al. Reducing the rehospitalization risk after a manic episode: a population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations. J Affect Disord. 2017;217:16–23. https://doi.org/10.1016/j.jad.2017.03.054.

    Article  PubMed  CAS  Google Scholar 

  30. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646. https://doi.org/10.1136/bmj.f3646.

    Article  PubMed  Google Scholar 

  31. Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry. 2012;69(5):515–28. https://doi.org/10.1001/archgenpsychiatry.2011.1508.

    Article  PubMed  CAS  Google Scholar 

  32. Salpekar JA, Joshi PT, Axelson DA, Reinblatt SP, Yenokyan G, Sanyal A, et al. Depression and suicidality outcomes in the treatment of early age mania study. J Am Acad Child Adolesc Psychiatry. 2015;54(12):999–1007 e4. https://doi.org/10.1016/j.jaac.2015.09.016.

  33. Walkup JT, Wagner KD, Miller L, Yenokyan G, Luby JL, Joshi PT, et al. Treatment of early-age mania: outcomes for partial and nonresponders to initial treatment. J Am Acad Child Adolesc Psychiatry. 2015;54(12):1008–19. https://doi.org/10.1016/j.jaac.2015.09.015.

    Article  PubMed  Google Scholar 

  34. Kafantaris V, Coletti D, Dicker R, Padula G, Kane JM. Lithium treatment of acute mania in adolescents: a large open trial. J Am Acad Child Adolesc Psychiatry. 2003;42(9):1038–45. https://doi.org/10.1097/01.CHI.0000070247.24125.24.

    Article  PubMed  Google Scholar 

  35. Kafantaris V, Coletti DJ, Dicker R, Padula G, Pleak RR, Alvir JM. Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry. 2004;43(8):984–93. https://doi.org/10.1097/01.chi.0000129223.89433.74.

    Article  PubMed  Google Scholar 

  36. Patel NC, DelBello MP, Bryan HS, Adler CM, Kowatch RA, Stanford K, et al. Open-label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry. 2006;45(3):289–97. https://doi.org/10.1097/01.chi.0000194569.70912.a7.

    Article  PubMed  Google Scholar 

  37. Findling RL, McNamara NK, Gracious BL, Youngstrom EA, Stansbrey RJ, Reed MD, et al. Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry. 2003;42(8):895–901. https://doi.org/10.1097/01.CHI.0000046893.27264.53.

    Article  PubMed  Google Scholar 

  38. Findling RL, McNamara NK, Stansbrey R, Gracious BL, Whipkey RE, Demeter CA, et al. Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization. J Am Acad Child Adolesc Psychiatry. 2006;45(2):142–8.

    Article  PubMed  Google Scholar 

  39. Pavuluri MN, Henry DB, Carbray JA, Sampson GA, Naylor MW, Janicak PG. A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. J Child Adolesc Psychopharmacol. 2006;16(3):336–50. https://doi.org/10.1089/cap.2006.16.336.

    Article  PubMed  Google Scholar 

  40. Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry. 2005;162(11):2152–61. https://doi.org/10.1176/appi.ajp.162.11.2152.

    Article  PubMed  Google Scholar 

  41. Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, et al. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(5):409–17.

    Article  PubMed  Google Scholar 

  42. Strakowski SM, DelBello MP, Fleck DE, Arndt S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry. 2000;48(6):477–85.

    Article  PubMed  CAS  Google Scholar 

  43. Geller B, Cooper TB, Sun K, Zimerman B, Frazier J, Williams M, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry. 1998;37(2):171–8. https://doi.org/10.1097/00004583-199802000-00009.

    Article  PubMed  CAS  Google Scholar 

  44. Masi G, Milone A, Manfredi A, Pari C, Paziente A, Millepiedi S. Effectiveness of lithium in children and adolescents with conduct disorder: a retrospective naturalistic study. CNS Drugs. 2009;23(1):59–69. https://doi.org/10.2165/0023210-200923010-00004.

    Article  PubMed  CAS  Google Scholar 

  45. Campbell M, Adams PB, Small AM, Kafantaris V, Silva RR, Shell J, et al. Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 1995;34(4):445–53.

    Article  PubMed  CAS  Google Scholar 

  46. Campbell M, Small AM, Green WH, Jennings SJ, Perry R, Bennett WG, et al. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry. 1984;41(7):650–6.

    Article  PubMed  CAS  Google Scholar 

  47. Berry-Kravis E, Sumis A, Hervey C, Nelson M, Porges SW, Weng N, et al. Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr. 2008;29(4):293–302. https://doi.org/10.1097/DBP.0b013e31817dc447.

    Article  PubMed  Google Scholar 

  48. Zhong J, Lee WH. Lithium: a novel treatment for Alzheimer’s disease? Expert Opin Drug Saf. 2007;6(4):375–83. https://doi.org/10.1517/14740338.6.4.375.

    Article  PubMed  CAS  Google Scholar 

  49. Kessing LV, Gerds TA, Knudsen NN, Jorgensen LF, Kristiansen SM, Voutchkova D, et al. Association of lithium in drinking water with the incidence of dementia. JAMA Psychiatry. 2017;74(10):1005–10. https://doi.org/10.1001/jamapsychiatry.2017.2362.

    Article  PubMed  PubMed Central  Google Scholar 

  50. McGrath JJ, Berk M. Could lithium in drinking water reduce the incidence of dementia? JAMA Psychiatry. 2017;74(10):983–4. https://doi.org/10.1001/jamapsychiatry.2017.2336.

    Article  PubMed  Google Scholar 

  51. Singh D, Akingbola A, Ross-Ascuitto N, Ascuitto R. Electrocardiac effects associated with lithium toxicity in children: an illustrative case and review of the pathophysiology. Cardiol Young. 2016;26(2):221–9.

    Article  PubMed  Google Scholar 

  52. Yacobi S, Ornoy A. Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. Isr J Psychiatry Relat Sci. 2008;45(2):95–106.

    PubMed  Google Scholar 

  53. Findling RL, Nyilas M, Forbes RA, McQuade RD, Jin N, Iwamoto T, et al. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2009;70(10):1441–51. https://doi.org/10.4088/JCP.09m05164yel.

    Article  PubMed  CAS  Google Scholar 

  54. Findling RL, Landbloom RL, Szegedi A, Koppenhaver J, Braat S, Zhu Q, et al. Asenapine for the acute treatment of pediatric manic or mixed episode of bipolar I disorder. J Am Acad Child Adolesc Psychiatry. 2015;54(12):1032–41. https://doi.org/10.1016/j.jaac.2015.09.007.

    Article  PubMed  Google Scholar 

  55. Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry. 2007;164(10):1547–56. https://doi.org/10.1176/appi.ajp.2007.06111932.

    Article  PubMed  Google Scholar 

  56. Pathak S, Findling RL, Earley WR, Acevedo LD, Stankowski J, Delbello MP. Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial. J Clin Psychiatry. 2013;74(1):e100–9. https://doi.org/10.4088/JCP.11m07424.

    Article  PubMed  CAS  Google Scholar 

  57. Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, et al. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2009;11(7):687–700. https://doi.org/10.1111/j.1399-5618.2009.00750.x.

    Article  PubMed  CAS  Google Scholar 

  58. Detke HC, DelBello MP, Landry J, Usher RW. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2015;54(3):217–24. https://doi.org/10.1016/j.jaac.2014.12.012.

    Article  PubMed  Google Scholar 

  59. Geller B, Fetner HH. Children’s 24-hour serum lithium level after a single dose predicts initial dose and steady-state plasma level. J Clin Psychopharmacol. 1989;9(2):155.

    Article  PubMed  CAS  Google Scholar 

  60. Singh LK, Nizamie SH, Akhtar S, Praharaj SK. Improving tolerability of lithium with a once-daily dosing schedule. Am J Ther. 2011;18(4):288–91. https://doi.org/10.1097/MJT.0b013e3181d070c3.

    Article  PubMed  Google Scholar 

  61. Kowatch RA, DelBello MP. The use of mood stabilizers and atypical antipsychotics in children and adolescents with bipolar disorders. CNS Spectr. 2003;8(4):273–80.

    Article  PubMed  Google Scholar 

  62. Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016;4(1):27. https://doi.org/10.1186/s40345-016-0068-y.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016;387(10023):1085–93. https://doi.org/10.1016/S0140-6736(16)00143-4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Duffy A, Patten S, Goodday S, Weir A, Heffer N, Cipriani A. Efficacy and tolerability of lithium in treating acute mania in youth with bipolar disorder: protocol for a systematic review. Int J Bipolar Disord. 2017;5(1):22. https://doi.org/10.1186/s40345-017-0092-6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Kennedy Krieger Institute, Johns Hopkins University School of Medicine, 716 N. Broadway, Baltimore, MD, 21205, USA

    B. Grant & J. A. Salpekar

Authors
  1. B. Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. A. Salpekar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Both authors participated in the writing, editing, and approval of this manuscript and had full control of content throughout development.

Corresponding author

Correspondence to J. A. Salpekar.

Ethics declarations

Funding

No sources of funding were used to conduct this study or prepare this manuscript.

Conflict of interest

Dr. Salpekar is a past educational  consultant for Sunovion, his institution receives research funding from Lundbeck, and he serves as a Data and Safety Monitoring Board chair for the National Institute of Mental Health. Dr. Grant has no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grant, B., Salpekar, J.A. Using Lithium in Children and Adolescents with Bipolar Disorder: Efficacy, Tolerability, and Practical Considerations. Pediatr Drugs 20, 303–314 (2018). https://doi.org/10.1007/s40272-018-0289-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40272-018-0289-x

Search

Navigation